Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Lonza buys Cambrex bioproducts and biopharma businesses

Executive Summary

To strengthen its focus within life sciences, Swiss firm Lonza Group is buying Cambrex Corp.'s bioproducts and biopharma divisions.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Vaccines
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Includes Contract
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register